Authors:
MALAMOS N
KOSMAS C
ANTONOPOULOS MJ
TSIKKINIS A
PALLIS L
PAPADIAMANTIS J
KOURI E
VASILAROS S
Citation: N. Malamos et al., PROSPECTIVE RANDOMIZED STUDY OF NEOADJUVANT CHEMOTHERAPY (NACT) WITH PACLITAXEL EPIRUBICIN (PE) VERSUS FLUOROURACIL/EPIRUBICIN/CYCLOPHOSPHAMIDE (FEC) IN OPERABLE STAGE II-IIIA BREAST-CANCER (BC)/, Annals of oncology, 9, 1998, pp. 105-105